Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
AFT Pharmaceuticals Ltd. ( (AU:AFP) ) has issued an announcement.
AFT Pharmaceuticals announced the retirement of its CFO, Malcolm Tubby, effective May 2026, and the appointment of Simon Bosley as CFO designate. This transition marks a strategic phase for AFT, as it continues its global expansion and aims to maintain its growth trajectory. Bosley, with his extensive financial expertise, is expected to support AFT’s strategy and drive the company’s next growth phase.
More about AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals is a New Zealand-based multinational company specializing in the development, marketing, and distribution of a wide range of medicines. Their portfolio includes proprietary and in-licensed products across various categories such as pain management, dermatology, eyecare, allergy, and gastroenterology. AFT operates directly in several countries including Australia, New Zealand, and the US, and partners with others globally.
Average Trading Volume: 3,460
Technical Sentiment Signal: Hold
Current Market Cap: A$292.3M
See more insights into AFP stock on TipRanks’ Stock Analysis page.